Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 5
2005 1
2006 1
2007 2
2008 4
2009 3
2010 1
2011 2
2012 4
2013 1
2014 4
2016 3
2017 3
2018 4
2020 1
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean xiao hong yu (134 results)?
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.
Carpenter EL, Van Decar S, Adams AM, O'Shea AE, McCarthy P, Chick RC, Clifton GT, Vreeland T, Valdera FA, Tiwari A, Hale D, Kemp Bohan P, Hickerson A, Smolinsky T, Thomas K, Cindass J, Hyngstrom J, Berger AC, Jakub J, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries M, Peoples GE. Carpenter EL, et al. Among authors: yu x. J Immunother Cancer. 2023 Aug;11(8):e006665. doi: 10.1136/jitc-2023-006665. J Immunother Cancer. 2023. PMID: 37536936 Free PMC article. Clinical Trial.
Novel dendritic cell-based vaccination in late stage melanoma.
Schneble EJ, Yu X, Wagner TE, Peoples GE. Schneble EJ, et al. Among authors: yu x. Hum Vaccin Immunother. 2014;10(11):3132-8. doi: 10.4161/hv.29110. Hum Vaccin Immunother. 2014. PMID: 25483650 Free PMC article. Review.
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial.
Adams AM, Carpenter EL, Clifton GT, Vreeland TJ, Chick RC, O'Shea AE, McCarthy PM, Kemp Bohan PM, Hickerson AT, Valdera FA, Tiwari A, Hale DF, Hyngstrom JR, Berger AC, Jakub JW, Sussman JJ, Shaheen MF, Yu X, Wagner TE, Faries MB, Peoples GE. Adams AM, et al. Among authors: yu x. Cancer Immunol Immunother. 2023 Mar;72(3):697-705. doi: 10.1007/s00262-022-03272-8. Epub 2022 Sep 1. Cancer Immunol Immunother. 2023. PMID: 36045304 Free PMC article. Clinical Trial.
48 results